Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan + 5-FU/LV vs 5-FU/LV in Advanced Colorectal Cancer
NCT00004885Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 1999
- Primary completion
- Jul 2001
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of irinotecan in metastatic colorectal cancer (mCRC), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 1999; status: completed.
02
Drugs
irinotecan
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00004885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004885.